ArticleFrontiers in immunology2021

PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic Cancer.

Yali Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.